This is the authors' abstract. We don't add key points for this paper.
Metabolic liver disease (MLD) is essentially a dynamic process of imbalance in metabolic homeostasis. The progression follows distinct stages from initial lipid deposition through inflammatory activation to fibrotic advancement, necessitating dynamic pathological staging and stage-specific therapeutic strategies. The largemouth bass ( Micropterus salmoides ), a carnivorous fish exhibiting inherent diabetic-like metabolism, has emerged as a novel experimental model for studying MLD progression. SHMT2 is a key enzyme in one-carbon metabolism, and plays an essential role in maintaining redox homeostasis, while p38α is activated in response to inflammation and oxidative stress. Both of these are involved in the regulation of human metabolic dysfunction-associated steatotic liver disease. In this study, we found that MLD in largemouth bass developed dynamically with long-term high-carbohydrate and high-lipid diet intake, manifested as early fat accumulation accompanied by mild fibrosis (early stage) and severe fibrosis (advanced stage). With the progression of liver disease, the activity of liver antioxidant enzymes increased significantly in the early stage, and the content of liver ROS was controlled at a low level. However, the antioxidant defense system collapsed, and ROS erupted in the advanced stage. The expression of autophagy related genes were significantly upregulated in the early stage to actively clear the damaged cells, while down-regulated in the advanced stage, leading to the accumulation of liver injury and a significant increase of cell apoptosis. Mechanistically, we identified a novel SHMT2-p38α interaction showing disease-stage-dependent modulation. This regulatory crosstalk appears to have dual roles by dynamically regulating ROS level, antioxidant enzyme activity and autophagy function during MLD progression. • Metabolic liver disease (MLD) in largemouth bass developed dynamically with long-term high-carbohydrate and high-lipid diet intake. • In the early stage of MLD, liver antioxidant enzyme activity and autophagy-related genes expression increased, maintaining ROS at a low level. • In the advanced stage, the antioxidant defense system collapsed and autophagy-related genes expression decreased, causing a surge in ROS levels. • SHMT2-p38α signaling dynamically regulates ROS levels, antioxidant enzyme activity, and autophagy function during the progression of MLD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: